Skip to the page

Data / Form D filings / Xenocor, Inc.

Xenocor, Inc.: Form D filing

Xenocor, Inc., a health care company in Salt Lake City, UT, filed a Form D with the SEC in 2023. The latest, on March 21, 2023, reports $5 million sold of a $10 million offering to 89 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
630 KOMAS DR., #200, Salt Lake City, UT, 84108
Phone
(435) 680-9782
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Utah
Year incorporated
2022
Revenue range
Not Applicable
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1967070

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 21, 2023New notice$10,000,000$4,957,167$5,042,83389Aug 5, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
SHAWN FOJTIKDirector
GEORGE BARANDirector
MARK FOSTERDirector
JIM HOGANDirector
ANTONY WATSONDirector
CHARLES DECOSTER IVExecutive Officer, Director
DINESH PATELDirector

Other health care companies in Utah that filed recently

Every Form D from the week of Mar 20, 2023 · All recent filings in Utah · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Xenocor, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.